Table of Contents
This TforG report includes the Surgical Procedures Database with 620 surgical interventions, reported by the ICD-9 coding system in Belgium. To add context to the surgical procedure volumes, the report provides written and numerical analysis on the current trends, size, changes and dynamics of the local markets. In addition, the latest reforms of the local Healthcare system are clearly outlined.
The report helps businesses gain a unique insight into the socio-economic dynamics until 2015, and helps analyze how they affect healthcare systems and their evolution. It can serve as an essential tool for sales, marketing, R&D and business managers with industry related interests.
Four chapters cover the numerical and written analysis for the following topics: Economic Outlook (38 Key industry indicators), The Healthcare System (HC system structures), Reforms (restructuring, re-engineering or austerity efforts) and the Healthcare Market (Capital Equipment, Medical Devices, Disposables and Pharmaceuticals).
The report includes 620 surgical interventions (in pdf format), reported by the ICD-9 international coding system in 13 specialisms, with data for six years: last year’s actuals (2014), four years of historical data, and one year of forecast. The specialisms included are: Cardiology, Neurology, Orthopedics, Urology, ENT, Ophthalmology, OBGYN, Endocrinology, Plastic, General, Thoracic, Hemic and Lymphatic system, Oncology.
-The GDP in 2014 was 402 bln Euro, equivalent to 36,086 Euro per capita, with an annual growth rate of 1.1 percent.
-Belgium is considered to be one of the most highly industrialized countries in the EU. It relies on importing raw materials in large volumes, processing them, and exporting them again successively.
-It has an advantageous logistical position located near the heart of Europe, well connected by sea and land. This innate benefit facilitates economic activity and growth.
-Exports are equal to 86 percent of its GDP, 75 percent of its trading partners are within the EU, and from amongst all the EU countries it ranks sixth as the largest importer and exporter of goods and services.
-Government spending was around 24.148 m Euro in the first quarter of 2015.
-Belgium ended 2014 with a budget deficit of 3.19 percent of GDP.
The Healthcare System:
-Funding for the healthcare system is pooled at a regional and federal level, and redistributed through the social security department.
-Healthcare spending in 2014 was equal to approximately 10.8 percent of the national GDP.
-76.1 percent of healthcare spending (not accounting for investments) was funded by public sources, higher than the OECD average of 72 percent. The remaining 23.9 percent was paid for by private sources including patient contributions.
-Approximately 2.8 percent of the total expenditure of healthcare in Belgium is spent on medical technology.
-Products and procedures can apply for inclusion into the nationally insured product catalogue issued by the national insurance provider RIZIV.
-Healthcare insurance coverage in Belgium is universal and mandatory. There are five major and competing public health insurance entities.
-Highly specialized care is mainly offered at university hospitals.
-Challenges that the Belgian healthcare faces include: that the reimbursement model does not reflect quality, the discrepancy in hospital doctor’s incomes, the greying of the population, the increasing underfinancing of hospitals leading to overproduction, and negative accounting balances in hospitals.
-Reforms include the 6th State Reform (2014), where a transference of tasks and financing allocates greater decision-making power to regional authorities.
-Public tenders (2013)
-Third-Payer-Regulation (2014) and Social Third-Payer-Regulation (2015)
-The Medical Device Plan (2014)
-The Belgian healthcare market is worth 4.5 bln Euro and forecasted to grow around 3.5 percent by 2018.
-The healthcare sector’s added value to the Belgian economy is equal to nearly eight percent of GDP and it employs twelve percent of the working population.
-There are over 200 active life sciences companies in Belgium, ranging from individual and/or interconnected small to medium-sized enterprises to large corporations.
-Belgium represents approximately 3.3 percent of the European medical technology market.
-The pharmaceutical market is worth approximately 4.49 bln Euro. The greatest markets within the pharmaceutical sector are reimbursed ambulatory drugs and drugs introduced into the market more than five years ago.
-An environment of cooperation and funding mechanisms have fostered collaborations for the pharma and life science R&D market in Belgium.
-Yearly over 2.35 bln Euro is invested into pharma R&D. Belgium ranks number two in the world as performing the highest number of clinical trials per capita.
Includes tables centralizing all relevant data on socio-demographics, macroeconomics and national Healthcare.
National Care Provision data:
Provides an overview of the Healthcare demographics: Nation Care provision data, Intensive Care units, Operating rooms, Emergency Rooms, Hospital services, Healthcare professionals.
Reasons to buy:
- Accurate analysis of trends, opportunities and challenges of the economy and healthcare industry
- Relevant healthcare reforms
- Written and numerical analysis on important healthcare indicators (eg.: acute care data, critical care data, anesthesia data, emergency data, healthcare professionals)
- Regularly updates, at least once year
- Every update published by TforG within 6 months after your purchase will be made available to you
- Global coverage, available for + 40 countries
- Surgical Procedure Volumes section incl. 620 ICD9 coded procedure volumes for five years: last year’s actuals (2014) (2014), three years of historical data, and two years of forecast
- Actionable information to capture size, trends and potential of the market
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
The global healthcare IT market is expected to grow at a CAGR of 15.9% from 2016 to 2021 and reach USD 280.25 billion. Growing need to manage regulatory compliance through healthcare IT solutions, government ...
The ultrasound market is expected to reach USD 6.86 billion by 2021 at a CAGR of 5.2% during 2016-2021. North America and Europe held the largest share of the market in 2016; however, the Asia-Pacific ...
EU5 Computed Tomography (CT) Systems Market Outlook to 2022 Summary GlobalData’s new report, "EU5 Computed Tomography (CT) Systems Market Outlook to 2022", provides key market data on the EU5 Computed ...